Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2014, vol. 23, nr 3, May-June, p. 433–440

Publication type: original article

Language: English

Multiple Neoplasms Among Cervical Cancer Patients in the Material of the Lower Silesian Cancer Registry

Barbara Izmajłowicz1,A,C,D, Jan Kornafel2,E,F, Jerzy Błaszczyk3,B

1 Department of Oncology, Gynecological Oncology clinic, Wroclaw Medical University, Lower Silesian Oncology center in Wroclaw, department of Gynecological Radiotherapy I, Poland

2 Department of Oncology, Gynecological Oncology clinic, Wroclaw Medical University, Poland

3 Lower Silesian Oncology center in Wroclaw, Lower Silesian cancer Registry Wroclaw, Poland

Abstract

Background. according to the definition by the International agency for Research on cancer (IaRc), primary multiple neoplasms are two or more neoplasms of different histopathological build in one organ, or two or more tumors occurring in one patient, regardless of the time of their occurrence (synchronic – up to 6 months, metachronous – after 6 months), coming from an organ or a tissue and not being an infiltration from another neoplasm, a relapse or a metastasis.
Objectives. It was the aim of the study to analyze the frequency of the occurrence of multiple neoplasms among patients suffering from uterine cervix cancer, with a special interest in coexistent neoplasms, the time of their occurrence and total 5-year survivals.
Material and Methods. The data from the Lower Silesian cancer Registry concerning the years 1984–2009 formed the material of the present study.
Results. 5.3% of all cervix neoplasms occurred as multiple cancers. cervix neoplasms were 13.4% of multiple neoplasms. On average, cervical cancer occurred as a subsequent cancer in 6 patients yearly (60.7% of the occurrences of cervical cancer were in the period of 5 years following treatment for the first neoplasm). 5-year survival in patients suffering from primarily multiple cervix neoplasms constituted 57% and was convergent with the results for all patients suffering from cervical cancer. cervical cancer as the first neoplasm occurred in 287 patients, on average in 11 patients annually. In the period of the first 5 years after the treatment of cervical cancer, there were 42.8% occurrences of other cancers. cervical neoplasms most frequently coexisted with cancers of the breast, lung and large intestine.
Conclusion. The frequency of the occurrence of multiple neoplasm among cervical cancer patients is increasing. Most frequently they coexist with other tobacco-related neoplasms, those related to HPV infections and with secondary post-radiation neoplasms. These facts should be taken into consideration during post-treatment observation and when directing diagnostic and prophylactic tests. Synchronic neoplasms require detailed diagnostics and planning of treatment by a team of specialists. The occurrence of primary multiple cervical neoplasms does not worsen the prognosis as compared to patients suffering exclusively from cervical cancer.

Key words

primary multiple neoplasms, synchronic neoplasms, metachronous neoplasms, cervical cancer.

References (29)

  1. IaRc (2004). International Rules for Multiple Primary cancers Icd-O Third edition. Internal Report No. 2004/02. Lyon: IaRc.
  2. Travis L: The epidemiology of second primary cancers. cancer epidemiol Biomarkers Prev 2006, 15, 2020–2026.
  3. Ng A, Travis L: Subsequent malignant neoplasms in cancer survivors. cancer J 2008, 14, 429–434.
  4. Gursel B, Meydan D, Ozbek N: Multiple primary malignant neoplasms from the black sea region of Turkey. J Int Res 2011, 39, 667–674.
  5. Didkowska J, Wojciechowska U: Liczba chorych na nowotwory złośliwe w Polsce w 2006 roku – chorobowość 5-letnia. Nowotwory 2011, 61, 332–335.
  6. SeeR program – National cancer Instittute, USa: http://www.seer.cancer.gov
  7. Wojciechowska U, Didkowska J, Zatoński W: Pięcioletnie przeżycia chorych na nowotwory złośliwe w Polsce. Nowotwory 2010, 60, 122–128.
  8. Błaszczyk J, Jagas M, Bębenek M: Przeżycia 5-letnie chorych na nowotwory złośliwe z lat 1985–2004 w woj. dolnośląskim, dolnośląski Rejestr Nowotworów, Wrocław 2011, 5–6.
  9. Demandante C, Troyer D, Miles T: Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. am J clin Oncol 2003, 26, 79–83.
  10. Crocetti E, Buiatti E, Fallini P: Multiple primary cancer incidence in Italy. eur J cancer 2001, 37, 2449–2456.
  11. Salem A, Abu-Hiijih R, Abdelrahman F: Multiple primary malignancies: analysis of 23 patients with at least three tumors. J Gastrointest cancer 2011, Jun 25. [epub ahead of print]
  12. Berrington de Gonzales A, Curtis R, Gilbert E: Proportion of secondo cancers attributable to radiotherapy treatment in adults: a kohort study in US SeeR cancer registries. Lancet Oncol 2011, 12, 353–360.
  13. Levi F, Randimbison L, Te V: Multiple primary cancers in the Vaud cancer Registry, Switzerland, 1974–1989. Br J cancer 1993, 67, 391–395.
  14. Chaturvedi a, Engels E, Gilbert E: Second cancers among 104 760 survivors of cervical cancer: evaluation of longterm risk. J Natl cancer Inst 2007, 99, 1634–1643.
  15. Werner-Wasik M, Schmid C, Bornstein L: Increased risk of secondo malignant neoplasms outside radiation fields in patients with cervical carcinoma. cancer 1995, 75, 2281–2285.
  16. dolnośląski Rejestr Nowotworów, Komitet ds. epidemiologii, Raport 1/2011: nowotwory mnogie w dRN, www. dco. com. pl.
  17. Axelrod J, Fruchter R, Boyce J: Multiple primaries among gynecologic malignancies. Gynecol Oncol 1984, 18, 359–372.
  18. Cheng H, Chu Ch, Chang W: clinical analysis of multiple primary malignancies in the digestive system: a hospital – based study. World J Gastroenterol 2005, 11, 4215–4219.
  19. Rose P, Herterick E, Boutselis J: Multiple primary gynecologic neoplasms. am J Obstet Gynecol 1987, 157, 261–267.
  20. Storm H, Ewertz M: Second cancer following cancer of the female genital system in denmark, 1943–1980. Natl cancer Inst Monogr 1985, 68, 331–340.
  21. Kapp D, Fischer D, Grady J: Subsequent malignancies associated with carcinoma of the uterine cervix: including an analysis of the effect of patient and treatment parameters on incidence and sites of metachronous malignancies. Int J Radiat Oncol Biol Phys 1982, 8, 197–205.
  22. Chaturvedi A, Kleinerman R, Hildesheim A: Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J clin Oncol 2009, 27, 967–973.
  23. Senkus E, Konefka T, Nowaczyk M: Second Lower genital tract squamous cell carcinoma following cervical cancer. a clinical study of 46 patients. acta Obstet Gynecol Scand 2000, 79, 765–770.
  24. Lee J, Moon W, Park S: Triple synchronous primary cancers of rectum, thyroid and uterine cervix detected during the workup for hematochezia. Inter Med. 2010, 49, 1745–1747.
  25. Kaczmarek A, Szydełko T: Nowotwory układu narządów moczowo-płciowych współistniejące z nowotworami innych narządów. Urol Pol 1989, 42, 1.
  26. Verstovsek S, Verschraegen C, Edwards C: Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment (clinico-patological conference). am J clin Oncol 2000, 23, 99–103.
  27. Baykal C, Baykal Y, Taskiran C: an extraordinary case of four primary tumors in the same patient, involving the uterine cervix, lung, skin, and rectum. eur J Gynaecol Oncol 2002, 23, 451–452.
  28. Świątoniowski G, Brużewicz Sz, Kłaniewski T: Radykalne leczenie chorej z trzema niezależnymi nowotworami złośliwymi. Onkol Prak Klin 2008, 4, 107–109.
  29. Lee T, Myers R, Scharyj M: Multiple primary malignant tumors (MPMT): study of 68 autopsy cases (1963–1980). J am Geriatr Soc 1982, 30, 744–753.
© Wroclaw Medical University